标题
Levodopa-induced dyskinesia: clinical features, incidence, and risk factors
作者
关键词
Parkinson’s disease, Dyskinesia, Adverse effects of levodopa
出版物
JOURNAL OF NEURAL TRANSMISSION
Volume 125, Issue 8, Pages 1109-1117
出版商
Springer Nature
发表日期
2018-07-03
DOI
10.1007/s00702-018-1900-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa–Induced Dyskinesia in Parkinson’s Disease
- (2017) Cristoforo Comi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dyskinesias in levodopa-carbidopa intestinal gel infusion era: New challenges, new features
- (2017) María-José Catalán et al. MOVEMENT DISORDERS
- Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3)
- (2017) Wolfgang Oertel et al. MOVEMENT DISORDERS
- Diphasic dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson's disease
- (2017) Mario Meloni et al. PARKINSONISM & RELATED DISORDERS
- ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study)
- (2017) Rajesh Pahwa et al. JAMA Neurology
- Levodopa in Parkinson’s Disease: Current Status and Future Developments
- (2017) Nicola Tambasco et al. Current Neuropharmacology
- Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
- (2016) Angelo Antonini et al. MOVEMENT DISORDERS
- Risk and course of motor complications in a population-based incident Parkinson's disease cohort
- (2016) Anders Bjornestad et al. PARKINSONISM & RELATED DISORDERS
- Motor complications in an incident Parkinson's disease cohort
- (2015) N. W. Scott et al. EUROPEAN JOURNAL OF NEUROLOGY
- Coffee consumption and risk of levodopa-induced dyskinesia in Parkinson's disease: The FRAGAMP study
- (2015) Alessandra Nicoletti et al. MOVEMENT DISORDERS
- Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)
- (2015) Rajesh Pahwa et al. MOVEMENT DISORDERS
- Levodopa-induced lateral jaw deviation dystonia
- (2015) Ronald F. Pfeiffer et al. PARKINSONISM & RELATED DISORDERS
- Is there a role for ADORA2A polymorphisms in levodopa-induced dyskinesia in Parkinson's disease patients?
- (2015) Mariana Rieck et al. PHARMACOGENOMICS
- The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
- (2014) R. Cilia et al. BRAIN
- Clinical spectrum of levodopa-induced complications
- (2014) Camila Catherine Aquino et al. MOVEMENT DISORDERS
- Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics
- (2014) Peter A. LeWitt MOVEMENT DISORDERS
- Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease
- (2014) J. Y. Hong et al. NEUROLOGY
- Dopamine agonist monotherapy in Parkinson's disease and potential risk factors for dyskinesia: a meta-analysis of levodopa-controlled trials
- (2013) M. Chondrogiorgi et al. EUROPEAN JOURNAL OF NEUROLOGY
- Risk factors and predictors of levodopa-induced dyskinesia among multiethnic Malaysians with Parkinson's disease
- (2013) H. Z. Hashim et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial
- (2013) Robert A Hauser et al. LANCET NEUROLOGY
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease
- (2013) C. Warren Olanow et al. MOVEMENT DISORDERS
- Caffeine consumption and risk of dyskinesia in CALM-PD
- (2013) Anne-Marie A. Wills et al. MOVEMENT DISORDERS
- The relationship between the phenotype of Parkinson's disease and levodopa-induced dyskinesia
- (2013) Yu-han Zhang et al. NEUROSCIENCE LETTERS
- Poor self-awareness of levodopa-induced dyskinesias in Parkinson's disease: Clinical features and mechanisms
- (2013) Sara Pietracupa et al. PARKINSONISM & RELATED DISORDERS
- Association of common genetic variants of HOMER1 gene with levodopa adverse effects in Parkinson’s disease patients
- (2013) A F Schumacher-Schuh et al. PHARMACOGENOMICS JOURNAL
- Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial
- (2012) Vincent JJ Odekerken et al. LANCET NEUROLOGY
- Subthalamic activity during diphasic dyskinesias in Parkinson's disease
- (2012) Manuel Alegre et al. MOVEMENT DISORDERS
- DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson’s disease patients
- (2012) Mariana Rieck et al. PHARMACOGENOMICS
- Resting Tremor in Parkinson Disease
- (2011) Stefan Kipfer ARCHIVES OF NEUROLOGY
- Glutamate NMDA receptor dysregulation in Parkinson’s disease with dyskinesias
- (2011) Imtiaz Ahmed et al. BRAIN
- Gender effect on time to levodopa-induced dyskinesias
- (2011) Sharon Hassin-Baer et al. JOURNAL OF NEUROLOGY
- Rhabdomyolysis induced by severe levodopa induced dyskinesia in a patient with Parkinson’s disease
- (2011) Chul Hyoung Lyoo et al. JOURNAL OF NEUROLOGY
- Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson's disease
- (2011) Lonneke M.L. de Lau et al. MOVEMENT DISORDERS
- “Silly Walks” in Parkinson's disease: Unusual presentation of dopaminergic-induced dyskinesias
- (2011) Evžen Růžička et al. MOVEMENT DISORDERS
- Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders
- (2010) Robert A. Hodgson et al. EXPERIMENTAL NEUROLOGY
- The clinical spectrum of levodopa-induced motor complications
- (2010) E. Hametner et al. JOURNAL OF NEUROLOGY
- Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap
- (2010) Paolo Calabresi et al. LANCET NEUROLOGY
- Levodopa-induced belly dancer's dyskinesias in Parkinson's disease: Report of one case
- (2010) Miryam Carecchio et al. MOVEMENT DISORDERS
- Age of Parkinson's disease onset as a predictor for the development of dyskinesia
- (2010) Stephen Ku et al. MOVEMENT DISORDERS
- Dyskinesia-hyperpyrexia syndrome: Another Parkinson's disease emergency
- (2010) Silvia Gil-Navarro et al. MOVEMENT DISORDERS
- Differential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson's disease
- (2010) Jee-Young Lee et al. MOVEMENT DISORDERS
- Classifying risk factors for dyskinesia in Parkinson’s disease
- (2010) J.C. Sharma et al. PARKINSONISM & RELATED DISORDERS
- The effect of onset age on the clinical features of Parkinson’s disease
- (2009) M. M. Wickremaratchi et al. EUROPEAN JOURNAL OF NEUROLOGY
- Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and Depression
- (2009) R. A. Hodgson et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The scientific and clinical basis for the treatment of Parkinson disease (2009)
- (2009) C. W. Olanow et al. NEUROLOGY
- Adenosine A2Areceptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)
- (2008) Peter A. LeWitt et al. ANNALS OF NEUROLOGY
- Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight
- (2008) J. C. Sharma et al. EUROPEAN JOURNAL OF NEUROLOGY
- Levodopa-Induced Dyskinesias in Parkinson’s Disease: Etiology, Impact on Quality of Life, and Treatments
- (2008) Elmyra V. Encarnacion et al. EUROPEAN NEUROLOGY
- BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease
- (2008) T Foltynie et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease
- (2008) M. Stacy et al. NEUROLOGY
- Dyskinesia-induced postural instability in Parkinson's disease
- (2008) Stéphane Armand et al. PARKINSONISM & RELATED DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started